FDA 483 - Contacare Ophthalmics & Diagnostics - November 01, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Contacare Ophthalmics & Diagnostics, a sterile drug manufacturer in Dabhasa, India, was cited for significant deficiencies in its aseptic processing, environmental monitoring, and quality control systems. The inspection revealed failures in personnel monitoring, media fills, sterility testing investigations, cleaning procedures, and validation of sterilization processes. Additionally, issues with complaint handling, documentation practices, and computer system controls indicate a broad lack of adherence to cGMP requirements, posing a high risk to product sterility and data integrity.
ID · a5c9992d-5e9d-4349-a426-d82d3727f4d4